Pancreatic Cancer Research

ResearcherKyoto Prefectural University of MedicineActive in the last 2 years

N. Iwai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6943-1605; OpenAlex author ID A5039090244. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Potential Role of Proton Beam Therapy for Locally Advanced Pancreatic Cancer. First author DOI 10.21873/anticanres.18260↗
  2. Interstitial Lung Disease Associated with Agaricus blazei Murill in a Patient with Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine-Based Therapy. Co-author DOI 10.1159/000522639↗
  3. Depletion of Psoas Muscle Mass after Systemic Chemotherapy Is Associated with Poor Prognosis in Patients with Unresectable Pancreatic Cancer. Co-author DOI 10.3390/cancers13153860↗
  4. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Co-author DOI 10.1038/s41598-020-75745-8↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoshito Itoh · 4 shared papers, 2020–2026 · strength 0.56
  2. Keisuke Takemura · 1 shared paper, 2026 · strength 0.23
  3. Kyohei Ikeda · 1 shared paper, 2026 · strength 0.23
  4. Toshifumi Doi · 1 shared paper, 2026 · strength 0.23
  5. Tomohisa Takagi · 1 shared paper, 2026 · strength 0.23
  6. Tomoki Sakakida · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.